Camber touts 14 generic intros in Q1

Camber Pharmaceuticals shared that it has successfully launched 14 new generic drugs in the first quarter of this year. 

This accomplishment, with nearly one new product introduced each week, reflects the exceptional collaboration between R&D, regulatory, quality control, supply chain, customer service and other internal teams, the company said.

[Read more: Camber launches generic Phenergan]

Oxcarbazepine Oral Suspension (Trileptal)

Atorvastatin Tablets (Lipitor)

Varenicline Tablets (Chantix)

Levonorgestrel & Ethinyl Estradiol Tablets (Alesse)

Theophylline ER Tablets (Theophylline)

Paliperidone ER Tablets (Invega)

Icosapent Ethyl Capsules (Vascepa)

Allopurinol Tablets (Zyloprim)

Quetiapine Fumarate Tablets (Seroquel)

Gabapentin Tablets (Gralise)

Aripiprazole Oral Solution (Abilify)

Pantoprazole Sodium DR Oral Suspension (Protonix)

Rufinamide Oral Suspension (Banzel)

Fesoterodine Tablets (Toviaz)